Behjati Farkhondeh, Firouzabadi Saghar Ghasemi, Kariminejad Roxana, Vameghi Roshanak, Sajedi Firouzeh, Shafaghati Yousef, Ghasemlou Behruz Ebrahimizade, Shojaei Azadeh, Jamali Peyman, Bahman Ideh, Najmabadi Hossein
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Kariminejad and Najmabadi Pathology and Genetics Center, Tehran, Iran.
Indian J Hum Genet. 2013 Oct;19(4):443-8. doi: 10.4103/0971-6866.124373.
Mental retardation (MR) has a prevalence of 1-3% and genetic causes are present in more than 50% of patients. Chromosomal abnormalities are one of the most common genetic causes of MR and are responsible for 4-28% of mental retardation. However, the smallest loss or gain of material visible by standard cytogenetic is about 4 Mb and for smaller abnormalities, molecular cytogenetic techniques such as array comparative genomic hybridization (array CGH) should be used. It has been shown that 15-25% of idiopathic MR (IMR) has submicroscopic rearrangements detectable by array CGH. In this project, the genomic abnormalities were investigated in 32 MR patients using this technique.
Patients with IMR with dysmorphism were investigated in this study. Karyotype analysis, fragile X and metabolic tests were first carried out on the patients. The copy number variation was then assessed in a total of 32 patients with normal results for the mentioned tests using whole genome oligo array CGH. Multiple ligation probe amplification was carried out as a confirmation test.
In total, 19% of the patients showed genomic abnormalities. This is reduced to 12.5% once the two patients with abnormal karyotypes (upon re-evaluation) are removed.
The array CGH technique increased the detection rate of genomic imbalances in our patients by 12.5%. It is an accurate and reliable method for the determination of genomic imbalances in patients with IMR and dysmorphism.
智力迟钝(MR)的患病率为1%-3%,超过50%的患者存在遗传病因。染色体异常是MR最常见的遗传病因之一,导致4%-28%的智力迟钝。然而,标准细胞遗传学所能检测到的最小物质增减约为4 Mb,对于较小的异常,应使用分子细胞遗传学技术,如阵列比较基因组杂交(array CGH)。已表明,15%-25%的特发性MR(IMR)存在可通过array CGH检测到的亚微观重排。在本项目中,使用该技术对32例MR患者的基因组异常进行了研究。
本研究对伴有畸形的IMR患者进行了调查。首先对患者进行核型分析、脆性X检测和代谢测试。然后,对上述测试结果正常的32例患者使用全基因组寡核苷酸阵列CGH评估拷贝数变异。进行多重连接探针扩增作为确认试验。
总体而言,19%的患者显示出基因组异常。一旦去除两名核型异常(重新评估后)的患者,这一比例降至12.5%。
array CGH技术使我们患者基因组失衡的检测率提高了12.5%。它是一种准确可靠的方法,用于确定伴有畸形的IMR患者的基因组失衡。